Cyclerion Therapeutics In... (CYCN)
Cyclerion Therapeutics Statistics
Share Statistics
Cyclerion Therapeutics has 3.21M shares outstanding. The number of shares has increased by 0% in one year.
| 3.21M |
| 0% |
| 0% |
| 0.02% |
| n/a |
| 1,792 |
| 8.8% |
Short Selling Information
The latest short interest is 25.09K, so 0.82% of the outstanding shares have been sold short.
| 25.09K |
| 0.82% |
| 1.03% |
| 1.56 |
Valuation Ratios
The PE ratio is -2.65 and the forward PE ratio is -0.15. Cyclerion Therapeutics's PEG ratio is 0.03.
| -2.65 |
| -0.15 |
| 4.05 |
| 0.1 |
| 0.92 |
| -1.87 |
| 0.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Cyclerion Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 5.83, with a Debt / Equity ratio of 0.
| 5.83 |
| 5.83 |
| 0 |
| n/a |
| n/a |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $2,000,000 |
| $-3,057,000 |
| 1 |
| 0.21 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by 19.62% in the last 52 weeks. The beta is 1.55, so Cyclerion Therapeutics's price volatility has been higher than the market average.
| 1.55 |
| 19.62% |
| 2.94 |
| 2.89 |
| 53.64 |
| 20,373 |
Income Statement
In the last 12 months, Cyclerion Therapeutics had revenue of 2M and earned -3.06M in profits. Earnings per share was -1.21.
| 2M |
| 2M |
| -3.63M |
| -3.06M |
| -3.63M |
| -3.63M |
| -1.21 |
Balance Sheet
The company has 3.23M in cash and 0 in debt, giving a net cash position of 3.23M.
| 3.23M |
| n/a |
| n/a |
| -267.49M |
| 9.85M |
| 3.43M |
Cash Flow
In the last 12 months, operating cash flow was -4.33M and capital expenditures 0, giving a free cash flow of -4.33M.
| -4.33M |
| n/a |
| -4.33M |
| -1.72 |
Margins
Gross margin is 100%, with operating and profit margins of -181.4% and -152.85%.
| 100% |
| -181.4% |
| -152.85% |
| -152.85% |
| -181.4% |
| -181.4% |
| -216.65% |
Dividends & Yields
CYCN does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on May 16, 2023. It was a backward split with a ratio of 1:20.
| May 16, 2023 |
| backward |
| 1:20 |
Scores
| -33.8 |
| 2 |